- Home
- GOSS vs TBI Comparison
GOSS vs TBI Comparison
Compare GOSS & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- TBI
- Stock Information
- Founded
- GOSS 2015
- TBI 1985
- Country
- GOSS United States
- TBI United States
- Employees
- GOSS N/A
- TBI N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- TBI Professional Services
- Sector
- GOSS Health Care
- TBI Consumer Discretionary
- Exchange
- GOSS Nasdaq
- TBI Nasdaq
- Market Cap
- GOSS 246.6M
- TBI 231.2M
- IPO Year
- GOSS 2019
- TBI 1996
- Fundamental
- Price
- GOSS $1.05
- TBI $7.50
- Analyst Decision
- GOSS Strong Buy
- TBI Buy
- Analyst Count
- GOSS 5
- TBI 2
- Target Price
- GOSS $9.20
- TBI $12.50
- AVG Volume (30 Days)
- GOSS 878.6K
- TBI 235.4K
- Earning Date
- GOSS 11-07-2024
- TBI 10-21-2024
- Dividend Yield
- GOSS N/A
- TBI N/A
- EPS Growth
- GOSS N/A
- TBI N/A
- EPS
- GOSS N/A
- TBI N/A
- Revenue
- GOSS $95,842,000.00
- TBI $1,764,450,000.00
- Revenue This Year
- GOSS N/A
- TBI N/A
- Revenue Next Year
- GOSS N/A
- TBI N/A
- P/E Ratio
- GOSS N/A
- TBI N/A
- Revenue Growth
- GOSS N/A
- TBI N/A
- 52 Week Low
- GOSS $0.45
- TBI $7.09
- 52 Week High
- GOSS $1.60
- TBI $16.14
- Technical
- Relative Strength Index (RSI)
- GOSS 58.40
- TBI 44.54
- Support Level
- GOSS $0.98
- TBI $7.31
- Resistance Level
- GOSS $1.07
- TBI $7.90
- Average True Range (ATR)
- GOSS 0.07
- TBI 0.28
- MACD
- GOSS 0.01
- TBI 0.02
- Stochastic Oscillator
- GOSS 64.44
- TBI 23.25
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.